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SHORT REPORT
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ABSTRACT
We demonstrate the presence of S100A8 and S100A9 proteins in the wall and thrombosed lumen of an
enlarged intracranial aneurysm after flow diverter treatment. These proteins have shown to play an import-
ant role in vascular inflammation and may serve as a biomarker and potential therapeutic target for intra-
cranial aneurysms.
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Case report
History and clinical course
A 52-year-old woman presented with progressive retro-orbital
pain and vomiting. Digital subtraction angiography (DSA) dem-
onstrated a giant aneurysm originating from the left internal
carotid artery (Figure 1(A)). Because of progressive symptomatol-
ogy, the aneurysm was treated with a single flow diverter (FD)
(Surpass Streamline, 4.0 30mm, Stryker Neurovascular,
Fremont, California, United States). Before placement, the patient
was given 500mg acetylsalicylic acid intravenously. Acetylsalicylic
acid (100mg, lifelong) and clopidogrel (75mg, 3 months) was
continued daily after the procedure. The patient was discharged
three days after treatment without residual neurological signs or
symptoms.
After two weeks, the patient returned with retro-orbital head-
aches and slight worsening of vision in the left eye. Her vision
further deteriorated in the following weeks (Online Supplement
1) and follow-up imaging was performed several times. Four
weeks after treatment, magnetic resonance angiography (MRA)
showed an almost completely thrombosed aneurysm with com-
pression on the optic chiasm and no signs of recent ischemia. Six
weeks after treatment, MRA and MRI with contrast showed no
significant changes compared with the first MRA except diffusion
restriction on diffusion-weighted imaging in the aneurysm lumen.
DSA showed a completely occluded aneurysm and patency of all
perforators, including the ophthalmic artery (Figure 1(B)).
Because the progressive vision loss did not respond to anti-
inflammatory medication, we decided to decompress the optic
chiasm by partial resection of the aneurysm. At surgery, compres-
sion of the optic chiasm and optic nerves was observed.
The aneurysm was covered by vasa vasorum (Online Supplement
2). The superior part of the aneurysm was debulked and aneur-
ysm tissue was collected from the wall and the intraluminal
thrombus for histological examination. Vasa vasorum was coagu-
lated to prevent bleeding. The patient recovered well and her vis-
ual fields and visual acuity was completely restored within 8
weeks after decompressive surgery (Online Supplement 1).
Thrombus organization and aneurysm regression without diffu-
sion restriction was seen on MRI 4 months after debulking.
Patient consent regarding publication was obtained.
Assessment of aneurysm volume
In order to assess aneurysm volume more precisely, subsequent
imaging studies were segmented using Horos (The Horos Project,
Version 2.0.0), Matlab (v.2016a) and 3ds Max (v.2016) (Figure
1(C)). The parent artery was excluded when calculating aneurysm
volume. An increase in aneurysm volume was observed 8 hours
after treatment (CT-perfusion, þ1.18 cm3 (18%)) and 6 weeks
after treatment (MRI, þ2.42 cm3 (36%)). This resulted
in compression of the optic chiasm and nerve. At 4 months’
follow-up, the aneurysm had decreased in volume.
Histology and immunohistochemistry
Collected tissues were fixed, embedded in paraffin and sectioned
at 4 mm. Haematoxylin and eosin (H&E) staining and immuno-
histochemistry (IHC) with custom-made anti-human S100A8 and
S100A9 antibodies were performed.
H&E stained material showed a thrombus in different stages
of organization. Some parts consisted of fresh, non-organized
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thrombus, while other parts were more organized with fibro-
blast-filled tissue (Figure 2(A)). Macrophages and neutrophils
were seen throughout the thrombus, both intact and partly
degraded.
IHC showed that both S100A8 and S100A9 proteins were
abundantly expressed in all samples (Figure 2(B,C)). Positive
staining was not only seen within macrophages and neutrophils,
but also in great amounts in the extracellular space. It was found
around degrading myeloid cells and in high amounts around
fibroblasts.
Discussion
S100/calgranulins
To our knowledge, this is the first report demonstrating the pres-
ence of S100A8 and S100A9 on IHC in an intracranial aneurysm.
Gene expression levels of S100A8 and S100A9 have recently
been found upregulated in both ruptured and unruptured intra-
cranial aneurysms, however no histological confirmation is
reported.1
S100A8 and S100A9 expression can be induced upon activa-
tion in endothelial cells, vascular smooth muscle cells (VSMC)
and fibroblasts. S100A8 and S100A9 expression amplifies the vas-
cular inflammatory reaction by activating the vascular
endothelium, inducing proliferation of VSMCs to the synthetic
cell type and promoting further influx of leukocytes by the
release of cytokines and chemokines.2
Previous reports have shown S100A8 and S100A9 to be an
important moderator of vascular disease.2 A 30% reduction in
atherosclerotic lesions was observed in S100A8 and S100A9
depleted mice due to a reduction of macrophages at lesion sites.
S100A8 and S100A9 depletion not only resulted in less athero-
sclerotic lesions but also in diminished neointimal thickening
after injury and smaller lesion size after thrombo-haemorrhagic
vasculitis.3 Similarities between aneurysms and atherosclerosis
make these findings interesting for the field of aneurysm
research.
S100 & enlargement
Flow diverter placement induces flow stagnation and rapid
thrombus formation. In some patients, expression of pro-
inflammatory cytokines in the freshly formed blood clot may
induce and sustain the inflammatory state of the thrombus and
prevent it from becoming stable. Vasa vasorum, seen during
surgery in our case, may provide an alternative pathway for the
influx of inflammatory cells as the aneurysm lumen is decoupled
from the parent artery. This might explain why the aneurysm
Figure 1. Cerebral DSA displaying a giant left ICA aneurysm before (A) and 7 weeks after (B) flow diverter treatment. 3D reconstructions of the aneurysms before and
6 weeks after flow-diverter placement (C). Axial view of pre-surgery (CT-A, dark) and 6 weeks post-surgery (MRI light). The ostium of the aneurysm is marked by a star.
Figure 2. Histological studies (50X). Haematoxylin & Eosin staining (A): Partly fresh, partly organized thrombus. S100A8 (B) and S100A9 (C) immunohistochemistry.
Focal spots of S100A8 S100A9 are seen in macrophages (Insert B, arrow) and a diffuse extracellular presence is seen around fibroblasts (circles).
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volume kept increasing after FD placement and why the throm-
bus displayed such a heterogeneous image despite occlusion
on DSA.
The observed aneurysm enlargement and the heterogeneous
histological image might be related to of the presence of cyto-
kines in general and more specifically of S100A8 and
S100A9 Calgranulins that could prolong the inflammatory
state of the thrombosed aneurysm.3 Future research should inves-
tigate the role of S100A8 and S100A9 in aneurysm healing and
rupture.
Clinical management
Clinical deterioration after FD placement has been reported pre-
viously. Conservative management usually leads to spontaneous
improvement, but in some cases FD placement leads to perman-
ent deficits or, even worse, delayed ruptures. Currently, it is
impossible to predict which aneurysms will progress beyond the
point where it leads to irreversible clinical problems. The pre-
sented patient experienced severe and progressive visual deterior-
ation, despite steroid treatment. In this case, we decided that
surgical debulking was the best option to prevent permanent
neurological damage.
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